On March 13, 2024, Mycenax Biotech Inc. cancelled the transaction. The transaction has been approved by the shareholders of the company.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
58.1 TWD | 0.00% |
|
-6.59% | +62.75% |
05-15 | Mycenax Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-14 | Mycenax Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+62.75% | 367M | |
+15.58% | 121B | |
+16.60% | 110B | |
+17.73% | 25.93B | |
-24.33% | 19.27B | |
-19.35% | 16.01B | |
-17.95% | 15.66B | |
-48.32% | 14.89B | |
+58.78% | 14.47B | |
+4.91% | 13.91B |
- Stock Market
- Equities
- 4726 Stock
- News Mycenax Biotech Inc.
- Mycenax Biotech Inc. cancelled the transaction announced on March 13, 2023